Impaired endothelial progenitor cell mobilization and colony-forming capacity in chronic obstructive pulmonary disease

Respirology

Volumn 16, Issue 4, 2011, Pages 680-687

  Takahashi, Toru ^a   Suzuki, Satoshi ^c   Kubo, Hiroshi ^b   Yamaya, Mutsuo ^b   Kurosawa, Shin ^a   Kato, Masato ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Ishinomaki Red Cross Hospital   (Japan)

Author keywords

chronic obstructive pulmonary disease; endothelial progenitor cell; smoking; thoracic surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; LUNG CANCER; LUNG RESECTION; MALE; PRIORITY JOURNAL; STEM CELL MOBILIZATION;

AGED; ANTIGENS, CD34; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STEM CELLS; THORACIC SURGICAL PROCEDURES;

EID: 79955392468     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01959.x     Document Type: Article

References (32)

1. Young RP, Hopkins R, Eaton TE,. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur. Respir. J. 2007; 3: 616-22. (Pubitemid 351194819)
2. Peinado VI, Pizarro S, Barber JA,. Pulmonary vascular involvement in COPD. Chest 2008; 134: 808-14.
3. Hunninghake DB,. Cardiovascular disease in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005; 2: 44-9. (Pubitemid 40562962)
4. Maclay JD, McAllister DA, MacNee W,. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007; 12: 634-41. (Pubitemid 47414891)
5. Iwamoto H, Yokoyama A, Kitahara Y, et al,. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am. J. Respir. Crit. Care Med. 2009; 179: 35-40.
6. Sin DD, Wu L, Man SF,. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-9.
7. Werner N, Kosiol S, Schiegl T, et al,. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005; 353: 999-1007. (Pubitemid 41262334)
8. Yamada M, Kubo H, Ishizawa K, et al,. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 2005; 60: 410-13. (Pubitemid 40685824)
9. Burnham EL, Taylor WR, Quyyumi AA, et al,. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am. J. Respir. Crit. Care Med. 2005; 172: 854-60. (Pubitemid 41369069)
10. Rafat N, Hanusch C, Brinkkoetter PT, et al,. Increased circulating endothelial progenitor cells in septic patients: correlation with survival. Crit. Care Med. 2007; 35: 1677-84. (Pubitemid 46985869)
11. Gill M, Dias S, Hattori K, et al,. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res. 2001; 88: 167-74. (Pubitemid 32147304)
12. Fadini GP, Schiavon M, Cantini M, et al,. Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells 2006; 24: 1806-13. (Pubitemid 44474194)
13. Huertas A, Testa U, Riccioni R, et al,. Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-BMI. Respir. Physiol. Neurobiol. 2010; 170: 23-31.
14. Pauwels RA, Buist AS, Calverley PM, et al,.; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-76. (Pubitemid 32378468)
15. Vasa M, Fichtlscherer S, Aicher A, et al,. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 2001; 89: E1-7.
16. Grisar J, Steiner CW, Bonelli M, et al,. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology 2008; 47: 1476-83.
17. Hill JM, Zalos G, Halcox JP, et al,. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003; 348: 593-600. (Pubitemid 36204953)
18. Asahara T, Masuda H, Takahashi T, et al,. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 1999; 85: 221-8. (Pubitemid 29377293)
19. Aicher A, Rentsch M, Sasaki K, et al,. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ. Res. 2007; 100: 581-9. (Pubitemid 46673268)
20. Ergün S, Tilki D, Hohn HP, et al,. Potential implications of vascular wall resident endothelial progenitor cells. Thromb. Haemost. 2007; 98: 930-9. (Pubitemid 350091120)
21. Heiss C, Amabile N, Lee AC, et al,. Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J. Am. Coll. Cardiol. 2008; 51: 1760-71. (Pubitemid 351608499)
22. Smadja DM, Godier A, Susen S, et al,. Endothelial progenitor cells are selectively mobilized immediately after coronary artery bypass. Thromb. Haemost. 2009; 101: 983-5.
23. Shaked Y, Ciarrocchi A, Franco M, et al,. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313: 1785-7. (Pubitemid 44454154)
24. Condon ET, Wang JH, Redmond HP,. Surgical injury induces the mobilization of endothelial progenitor cells. Surgery 2004; 135: 657-61. (Pubitemid 38879349)
25. Shimanuki Y, Takahashi K, Chi R, et al,. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer. Lung 2005; 183: 29-42. (Pubitemid 41264745)
26. Katsabeki-Katsafli A, Kerenidi T, Kostikas K, et al,. Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer. Lung Cancer 2008; 60: 271-6.
27. Conklin BS, Zhao W, Zhong DS, et al,. Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am. J. Pathol. 2002; 160: 413-18. (Pubitemid 34160317)
28. Inoue M, Itoh H, Ueda M, et al,. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998; 98: 2108-16. (Pubitemid 28527469)
29. George J, Shmilovich H, Deutsch V, et al,. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 2006; 12: 331-5.
30. Palange P, Testa U, Huertas A, et al,. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur. Respir. J. 2006; 27: 529-41. (Pubitemid 43372527)
31. Sala E, Villena C, Balaguer C, et al,. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD. Lung 2010; 188: 331-8.
32. Nowak K, Rafat N, Belle S, et al,. Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur. J. Cardiothorac. Surg. 2010; 37: 758-63.